1 Introduction to Research & Analysis Reports
1.1 Opiate Antagonist Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Opiate Antagonist Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Opiate Antagonist Overall Market Size
2.1 Global Opiate Antagonist Market Size: 2022 VS 2029
2.2 Global Opiate Antagonist Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Opiate Antagonist Players in Global Market
3.2 Top Global Opiate Antagonist Companies Ranked by Revenue
3.3 Global Opiate Antagonist Revenue by Companies
3.4 Top 3 and Top 5 Opiate Antagonist Companies in Global Market, by Revenue in 2022
3.5 Global Companies Opiate Antagonist Product Type
3.6 Tier 1, Tier 2 and Tier 3 Opiate Antagonist Players in Global Market
3.6.1 List of Global Tier 1 Opiate Antagonist Companies
3.6.2 List of Global Tier 2 and Tier 3 Opiate Antagonist Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Opiate Antagonist Market Size Markets, 2022 & 2029
4.1.2 0.4 mg/ml
4.1.3 1 mg/ml
4.1.4 2 mg/ml
4.2 By Type – Global Opiate Antagonist Revenue & Forecasts
4.2.1 By Type – Global Opiate Antagonist Revenue, 2018-2023
4.2.2 By Type – Global Opiate Antagonist Revenue, 2024-2029
4.2.3 By Type – Global Opiate Antagonist Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Opiate Antagonist Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Pharmacy
5.1.5 Home
5.1.6 Others
5.2 By Application – Global Opiate Antagonist Revenue & Forecasts
5.2.1 By Application – Global Opiate Antagonist Revenue, 2018-2023
5.2.2 By Application – Global Opiate Antagonist Revenue, 2024-2029
5.2.3 By Application – Global Opiate Antagonist Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Opiate Antagonist Market Size, 2022 & 2029
6.2 By Region – Global Opiate Antagonist Revenue & Forecasts
6.2.1 By Region – Global Opiate Antagonist Revenue, 2018-2023
6.2.2 By Region – Global Opiate Antagonist Revenue, 2024-2029
6.2.3 By Region – Global Opiate Antagonist Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Opiate Antagonist Revenue, 2018-2029
6.3.2 US Opiate Antagonist Market Size, 2018-2029
6.3.3 Canada Opiate Antagonist Market Size, 2018-2029
6.3.4 Mexico Opiate Antagonist Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Opiate Antagonist Revenue, 2018-2029
6.4.2 Germany Opiate Antagonist Market Size, 2018-2029
6.4.3 France Opiate Antagonist Market Size, 2018-2029
6.4.4 U.K. Opiate Antagonist Market Size, 2018-2029
6.4.5 Italy Opiate Antagonist Market Size, 2018-2029
6.4.6 Russia Opiate Antagonist Market Size, 2018-2029
6.4.7 Nordic Countries Opiate Antagonist Market Size, 2018-2029
6.4.8 Benelux Opiate Antagonist Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Opiate Antagonist Revenue, 2018-2029
6.5.2 China Opiate Antagonist Market Size, 2018-2029
6.5.3 Japan Opiate Antagonist Market Size, 2018-2029
6.5.4 South Korea Opiate Antagonist Market Size, 2018-2029
6.5.5 Southeast Asia Opiate Antagonist Market Size, 2018-2029
6.5.6 India Opiate Antagonist Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Opiate Antagonist Revenue, 2018-2029
6.6.2 Brazil Opiate Antagonist Market Size, 2018-2029
6.6.3 Argentina Opiate Antagonist Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Opiate Antagonist Revenue, 2018-2029
6.7.2 Turkey Opiate Antagonist Market Size, 2018-2029
6.7.3 Israel Opiate Antagonist Market Size, 2018-2029
6.7.4 Saudi Arabia Opiate Antagonist Market Size, 2018-2029
6.7.5 UAE Opiate Antagonist Market Size, 2018-2029
7 Opiate Antagonist Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Opiate Antagonist Major Product Offerings
7.1.4 Pfizer Opiate Antagonist Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Sun Pharmaceutical Industries
7.2.1 Sun Pharmaceutical Industries Company Summary
7.2.2 Sun Pharmaceutical Industries Business Overview
7.2.3 Sun Pharmaceutical Industries Opiate Antagonist Major Product Offerings
7.2.4 Sun Pharmaceutical Industries Opiate Antagonist Revenue in Global Market (2018-2023)
7.2.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.3 Teva Pharmaceuticals
7.3.1 Teva Pharmaceuticals Company Summary
7.3.2 Teva Pharmaceuticals Business Overview
7.3.3 Teva Pharmaceuticals Opiate Antagonist Major Product Offerings
7.3.4 Teva Pharmaceuticals Opiate Antagonist Revenue in Global Market (2018-2023)
7.3.5 Teva Pharmaceuticals Key News & Latest Developments
7.4 Cardinal Health
7.4.1 Cardinal Health Company Summary
7.4.2 Cardinal Health Business Overview
7.4.3 Cardinal Health Opiate Antagonist Major Product Offerings
7.4.4 Cardinal Health Opiate Antagonist Revenue in Global Market (2018-2023)
7.4.5 Cardinal Health Key News & Latest Developments
7.5 Baxter Pharmaceutical
7.5.1 Baxter Pharmaceutical Company Summary
7.5.2 Baxter Pharmaceutical Business Overview
7.5.3 Baxter Pharmaceutical Opiate Antagonist Major Product Offerings
7.5.4 Baxter Pharmaceutical Opiate Antagonist Revenue in Global Market (2018-2023)
7.5.5 Baxter Pharmaceutical Key News & Latest Developments
7.6 Adapt Pharmaceuticals
7.6.1 Adapt Pharmaceuticals Company Summary
7.6.2 Adapt Pharmaceuticals Business Overview
7.6.3 Adapt Pharmaceuticals Opiate Antagonist Major Product Offerings
7.6.4 Adapt Pharmaceuticals Opiate Antagonist Revenue in Global Market (2018-2023)
7.6.5 Adapt Pharmaceuticals Key News & Latest Developments
7.7 Dr. Reddy’s Laboratories
7.7.1 Dr. Reddy’s Laboratories Company Summary
7.7.2 Dr. Reddy’s Laboratories Business Overview
7.7.3 Dr. Reddy’s Laboratories Opiate Antagonist Major Product Offerings
7.7.4 Dr. Reddy’s Laboratories Opiate Antagonist Revenue in Global Market (2018-2023)
7.7.5 Dr. Reddy’s Laboratories Key News & Latest Developments
7.8 GIV Repack
7.8.1 GIV Repack Company Summary
7.8.2 GIV Repack Business Overview
7.8.3 GIV Repack Opiate Antagonist Major Product Offerings
7.8.4 GIV Repack Opiate Antagonist Revenue in Global Market (2018-2023)
7.8.5 GIV Repack Key News & Latest Developments
7.9 Intl Medication Systems
7.9.1 Intl Medication Systems Company Summary
7.9.2 Intl Medication Systems Business Overview
7.9.3 Intl Medication Systems Opiate Antagonist Major Product Offerings
7.9.4 Intl Medication Systems Opiate Antagonist Revenue in Global Market (2018-2023)
7.9.5 Intl Medication Systems Key News & Latest Developments
7.10 Kaleo Pharma
7.10.1 Kaleo Pharma Company Summary
7.10.2 Kaleo Pharma Business Overview
7.10.3 Kaleo Pharma Opiate Antagonist Major Product Offerings
7.10.4 Kaleo Pharma Opiate Antagonist Revenue in Global Market (2018-2023)
7.10.5 Kaleo Pharma Key News & Latest Developments
7.11 Mylan Institutional
7.11.1 Mylan Institutional Company Summary
7.11.2 Mylan Institutional Business Overview
7.11.3 Mylan Institutional Opiate Antagonist Major Product Offerings
7.11.4 Mylan Institutional Opiate Antagonist Revenue in Global Market (2018-2023)
7.11.5 Mylan Institutional Key News & Latest Developments
7.12 Perrigo Pharmaceuticals
7.12.1 Perrigo Pharmaceuticals Company Summary
7.12.2 Perrigo Pharmaceuticals Business Overview
7.12.3 Perrigo Pharmaceuticals Opiate Antagonist Major Product Offerings
7.12.4 Perrigo Pharmaceuticals Opiate Antagonist Revenue in Global Market (2018-2023)
7.12.5 Perrigo Pharmaceuticals Key News & Latest Developments
7.13 AuroMedics Pharma
7.13.1 AuroMedics Pharma Company Summary
7.13.2 AuroMedics Pharma Business Overview
7.13.3 AuroMedics Pharma Opiate Antagonist Major Product Offerings
7.13.4 AuroMedics Pharma Opiate Antagonist Revenue in Global Market (2018-2023)
7.13.5 AuroMedics Pharma Key News & Latest Developments
7.14 Somerset Pharma
7.14.1 Somerset Pharma Company Summary
7.14.2 Somerset Pharma Business Overview
7.14.3 Somerset Pharma Opiate Antagonist Major Product Offerings
7.14.4 Somerset Pharma Opiate Antagonist Revenue in Global Market (2018-2023)
7.14.5 Somerset Pharma Key News & Latest Developments
7.15 Akorn
7.15.1 Akorn Company Summary
7.15.2 Akorn Business Overview
7.15.3 Akorn Opiate Antagonist Major Product Offerings
7.15.4 Akorn Opiate Antagonist Revenue in Global Market (2018-2023)
7.15.5 Akorn Key News & Latest Developments
7.16 Alkermes
7.16.1 Alkermes Company Summary
7.16.2 Alkermes Business Overview
7.16.3 Alkermes Opiate Antagonist Major Product Offerings
7.16.4 Alkermes Opiate Antagonist Revenue in Global Market (2018-2023)
7.16.5 Alkermes Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
世界のオピエートきっ抗剤市場予測2023-2029：0.4mg/ml、1mg/ml、2mg/ml |
| 【英語タイトル】Opiate Antagonist Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5835 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：106 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界のオピエートきっ抗剤市場規模と予測を収録しています。・世界のオピエートきっ抗剤市場：売上、2018年-2023年、2024年-2029年 ・世界のオピエートきっ抗剤市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のオピエートきっ抗剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「0.4mg/ml」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 オピエートきっ抗剤のグローバル主要企業は、Pfizer、 Sun Pharmaceutical Industries、 Teva Pharmaceuticals、 Cardinal Health、 Baxter Pharmaceutical、 Adapt Pharmaceuticals、 Dr. Reddy's Laboratories、 GIV Repack、 Intl Medication Systems、 Kaleo Pharma、 Mylan Institutional、 Perrigo Pharmaceuticals、 AuroMedics Pharma、 Somerset Pharma、 Akorn、 Alkermesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、オピエートきっ抗剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のオピエートきっ抗剤市場：タイプ別、2018年-2023年、2024年-2029年 世界のオピエートきっ抗剤市場：タイプ別市場シェア、2022年 ・0.4mg/ml、1mg/ml、2mg/ml 世界のオピエートきっ抗剤市場：用途別、2018年-2023年、2024年-2029年 世界のオピエートきっ抗剤市場：用途別市場シェア、2022年 ・病院、診療所、薬局、家庭、その他 世界のオピエートきっ抗剤市場：地域・国別、2018年-2023年、2024年-2029年 世界のオピエートきっ抗剤市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるオピエートきっ抗剤のグローバル売上、2018年-2023年 ・主要企業におけるオピエートきっ抗剤のグローバル売上シェア、2022年 ・主要企業におけるオピエートきっ抗剤のグローバル販売量、2018年-2023年 ・主要企業におけるオピエートきっ抗剤のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Pfizer、 Sun Pharmaceutical Industries、 Teva Pharmaceuticals、 Cardinal Health、 Baxter Pharmaceutical、 Adapt Pharmaceuticals、 Dr. Reddy's Laboratories、 GIV Repack、 Intl Medication Systems、 Kaleo Pharma、 Mylan Institutional、 Perrigo Pharmaceuticals、 AuroMedics Pharma、 Somerset Pharma、 Akorn、 Alkermes ************************************************************* ・調査・分析レポートの概要 オピエートきっ抗剤市場の定義 市場セグメント 世界のオピエートきっ抗剤市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のオピエートきっ抗剤市場規模 世界のオピエートきっ抗剤市場規模：2022年 VS 2029年 世界のオピエートきっ抗剤市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのオピエートきっ抗剤の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のオピエートきっ抗剤製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：0.4mg/ml、1mg/ml、2mg/ml オピエートきっ抗剤のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、薬局、家庭、その他 オピエートきっ抗剤の用途別グローバル売上・予測 ・地域別市場分析 地域別オピエートきっ抗剤市場規模 2022年と2029年 地域別オピエートきっ抗剤売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Pfizer、 Sun Pharmaceutical Industries、 Teva Pharmaceuticals、 Cardinal Health、 Baxter Pharmaceutical、 Adapt Pharmaceuticals、 Dr. Reddy's Laboratories、 GIV Repack、 Intl Medication Systems、 Kaleo Pharma、 Mylan Institutional、 Perrigo Pharmaceuticals、 AuroMedics Pharma、 Somerset Pharma、 Akorn、 Alkermes ... |
This report aims to provide a comprehensive presentation of the global market for Opiate Antagonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opiate Antagonist. This report contains market size and forecasts of Opiate Antagonist in global, including the following market information:
Global Opiate Antagonist Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Opiate Antagonist market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
0.4 mg/ml Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Opiate Antagonist include Pfizer, Sun Pharmaceutical Industries, Teva Pharmaceuticals, Cardinal Health, Baxter Pharmaceutical, Adapt Pharmaceuticals, Dr. Reddy’s Laboratories, GIV Repack and Intl Medication Systems, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Opiate Antagonist companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Opiate Antagonist Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Opiate Antagonist Market Segment Percentages, by Type, 2022 (%)
0.4 mg/ml
1 mg/ml
2 mg/ml
Global Opiate Antagonist Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Opiate Antagonist Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinics
Pharmacy
Home
Others
Global Opiate Antagonist Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Opiate Antagonist Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Opiate Antagonist revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Opiate Antagonist revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Sun Pharmaceutical Industries
Teva Pharmaceuticals
Cardinal Health
Baxter Pharmaceutical
Adapt Pharmaceuticals
Dr. Reddy’s Laboratories
GIV Repack
Intl Medication Systems
Kaleo Pharma
Mylan Institutional
Perrigo Pharmaceuticals
AuroMedics Pharma
Somerset Pharma
Akorn
Alkermes
Outline of Major Chapters:
Chapter 1: Introduces the definition of Opiate Antagonist, market overview.
Chapter 2: Global Opiate Antagonist market size in revenue.
Chapter 3: Detailed analysis of Opiate Antagonist company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Opiate Antagonist in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界のオピエートきっ抗剤市場予測2023-2029：0.4mg/ml、1mg/ml、2mg/ml] (コード：MMG23JU5835)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のオピエートきっ抗剤市場予測2023-2029：0.4mg/ml、1mg/ml、2mg/ml]についてメールでお問い合わせ |
